New Data Supports Effectiveness of VivAer Nasal Airway Obstruction Device
New data confirms VivAer provides consistent and long-lasting symptom relief for patients suffering from nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
New data confirms VivAer provides consistent and long-lasting symptom relief for patients suffering from nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
New data confirms VivAer provides consistent and long-lasting symptom relief for patients suffering from nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
Read MoreNasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read MoreThe actor best known for his roles in Top Gun, Tombstone, Heat, Batman Forever, and The Doors, passed away Tuesday at the age of 65 due to pneumonia.
Read MoreAdenotonsillectomy was tied to a 32% reduction in medical visits and a 48% reduction in prescription use among children with mild sleep-disordered breathing.
Read MorePatients using mepolizumab (Nucala) experienced significant improvement in nasal polyps, nasal obstruction, smell and overall symptoms.
Read MoreThe digital video monitor is an all-in-one video processor and monitor for use with single-use endoscopes for both bronchoscopy and ENT.
Read MoreThe Centers for Medicare and Medicaid Services (CMS) recently assigned a CPT reimbursement code for the Neuromark System, Neurent Medical’s chronic rhinitis treatment.
Read MoreChronic rhinitis patients treated with the Neuromark System demonstrated significant improvement in rhinorrhea and nasal congestion symptoms at 3 months, according to new data.
Read MoreThe American Medical Association Current Procedural Terminology (CPT) Editorial Panel accepted the application for a new Category I CPT code to report endoscopic destruction of the posterior nasal nerve using radiofrequency (RF) ablation, according to Aerin Medical Inc.
Read MoreAmong in ANCA-associated vasculitis patients, Avacopan was better than Prednisone in reducing respiratory and ear, nose and throat (ENT) involvement, while reducing glucocorticoid use.
Read MoreMedtronic plc has completed the acquisition of Intersect ENT, expanding the company’s comprehensive ear, nose, and throat (ENT) portfolio with products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.
Read MoreThe FDA has cleared the Neuromark Rhinitis Neurolysis Therapy (RNT), an in-office treatment designed to create lesions to disrupt the posterior nasal nerves, for patients with chronic rhinitis, according to Neurent Medical.
Read MoreCertain patient characteristics can increase likelihood of a successful outcome following a surgical procedure called uvopalatopharyngoplasty.
Read MoreA procedure known as uvulopalatopharyngoplasty (UPPP) may help eliminate OSA, according to study results presented at Chest 2007.
Read MoreProper management of sleep apnea can reduce the significant consequences of this disorder, which can include frequent arousals, daytime sleepiness, even death.
Read MoreObesity can exacerbate OSA and presents special intubation problems. RTs need to be prepared with strategies when treating this patient population.
Read More